| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access to melanoma drugs in Spain: a cross-sectional survey
|
Gonzalez-Cao, Maria
|
|
|
26 |
10 |
p. 2572-2583
|
artikel
|
| 2 |
Akkermania muciniphila: a rising star in tumor immunology
|
Wang, Leihan
|
|
|
26 |
10 |
p. 2418-2430
|
artikel
|
| 3 |
An analysis of the association between breast density and body mass index with breast cancer molecular subtypes in early breast cancer: data from a Spanish population
|
Calvo, Isabel
|
|
|
26 |
10 |
p. 2541-2548
|
artikel
|
| 4 |
An overview of current research on cancer stem cells: a bibliometric analysis
|
Zhang, Xueyang
|
|
|
26 |
10 |
p. 2466-2478
|
artikel
|
| 5 |
Assessing clinical pathological characteristics and gene expression patterns associated with hepatoid adenocarcinoma of the stomach
|
Ge, Dong-Feng
|
|
|
26 |
10 |
p. 2674-2684
|
artikel
|
| 6 |
Challenges of diagnosing homologous recombination deficiencies in metastatic prostate cancer: a six-year experience from a single institution
|
Gavira, Javier
|
|
|
26 |
10 |
p. 2749-2753
|
artikel
|
| 7 |
Clinical difference on the variants and co-mutation in a Chinese cohort with ALK-positive advanced non-small cell lung cancer
|
Fu, Ying
|
|
|
26 |
10 |
p. 2513-2521
|
artikel
|
| 8 |
Clinical efficacy of lenvatinib, trans-arterial chemoembolization, and PD-1/L1 inhibitors in advanced hepatocellular carcinoma: a systematic review and network meta-analysis
|
Liang, YiFeng
|
|
|
26 |
10 |
p. 2652-2664
|
artikel
|
| 9 |
Comparative effectiveness of first-line systemic treatments for metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
|
Ai, Jiahuan
|
|
|
26 |
10 |
p. 2559-2571
|
artikel
|
| 10 |
Comparison of efficacy and safety of PD-1/PD-L1 combination therapy in first-line treatment of advanced NSCLC: an updated systematic review and network meta-analysis
|
Yang, Yanqing
|
|
|
26 |
10 |
p. 2488-2502
|
artikel
|
| 11 |
Comprehensive pan-cancer analysis reveals prognostic implications of TMEM92 in the tumor immune microenvironment
|
Wu, Zheng
|
|
|
26 |
10 |
p. 2701-2717
|
artikel
|
| 12 |
Determining individual suitability for neoadjuvant systemic therapy in breast cancer patients through deep learning
|
Zhu, Enzhao
|
|
|
26 |
10 |
p. 2584-2593
|
artikel
|
| 13 |
Development and validation of a nomogram to predicting the efficacy of PD-1/PD-L1 inhibitors in patients with nasopharyngeal carcinoma
|
Chen, Yao
|
|
|
26 |
10 |
p. 2601-2607
|
artikel
|
| 14 |
Efficacy and safety analysis of immunotherapy in non-small cell lung cancer patients with MET alterations
|
Wang, Yanhua
|
|
|
26 |
10 |
p. 2503-2512
|
artikel
|
| 15 |
Exploration of efficacy of different therapy regimens for advanced NSCLC patients with KRAS mutation in the first-line treatment
|
Wang, Ke
|
|
|
26 |
10 |
p. 2479-2487
|
artikel
|
| 16 |
External validation of the RIETE and SOME scores for occult cancer in patients with venous thromboembolism: a multicentre cohort study
|
Franco-Moreno, Anabel
|
|
|
26 |
10 |
p. 2685-2692
|
artikel
|
| 17 |
HER2/neu 655 polymorphism, trastuzumab-induced cardiotoxicity, and survival in HER2-positive breast cancer patients
|
Blancas, Isabel
|
|
|
26 |
10 |
p. 2531-2540
|
artikel
|
| 18 |
Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies
|
Liu, Qiaoqiao
|
|
|
26 |
10 |
p. 2395-2417
|
artikel
|
| 19 |
High MAL2 expression predicts shorter survival in women with triple-negative breast cancer
|
Borowczak, Jędrzej
|
|
|
26 |
10 |
p. 2549-2558
|
artikel
|
| 20 |
How appropriate is treating patients diagnosed with advanced esophageal cancer with anticancer drugs? A multicenter retrospective cohort Spanish study
|
Santero, Marilina
|
|
|
26 |
10 |
p. 2629-2639
|
artikel
|
| 21 |
Pancreatic ductal adenocarcinoma: exploring clinicopathological trends and racial disparities in a comprehensive U.S. population-based study
|
Yasinzai, Abdul Qahar Khan
|
|
|
26 |
10 |
p. 2618-2628
|
artikel
|
| 22 |
Peripheral NK cells identified as the predictor of response in extensive-stage small cell lung cancer patients treated with first-line immunotherapy plus chemotherapy
|
Cui, Yanan
|
|
|
26 |
10 |
p. 2522-2530
|
artikel
|
| 23 |
Prostate cancer biomarkers: from early diagnosis to precision treatment
|
Dahiya, Versha
|
|
|
26 |
10 |
p. 2444-2456
|
artikel
|
| 24 |
Recent updates in the therapeutic uses of Pembrolizumab: a brief narrative review
|
Silva, Vítor
|
|
|
26 |
10 |
p. 2431-2443
|
artikel
|
| 25 |
Sequential RAS mutations evaluation in cell-free DNA of patients with tissue RAS wild-type metastatic colorectal cancer: the PERSEIDA (Cohort 2) study
|
Valladares-Ayerbes, Manuel
|
|
|
26 |
10 |
p. 2640-2651
|
artikel
|
| 26 |
State of open science in cancer research
|
Rius, Cristina
|
|
|
26 |
10 |
p. 2457-2465
|
artikel
|
| 27 |
The cuproptosis-related gene UBE2D2 functions as an immunotherapeutic and prognostic biomarker in pan-cancer
|
Fei, Yao
|
|
|
26 |
10 |
p. 2718-2737
|
artikel
|
| 28 |
The effect of hyperbaric oxygen therapy in head and neck cancer patients with radiation induced dysphagia—a systematic review
|
Philipsen, Bahareh Bakhshaie
|
|
|
26 |
10 |
p. 2594-2600
|
artikel
|
| 29 |
Treatment benefit of electrochemotherapy for superficial squamous cell carcinoma: a systematic review and single-arm meta-analysis
|
Wu, Zhuoxia
|
|
|
26 |
10 |
p. 2608-2617
|
artikel
|
| 30 |
Unveiling sex-based geographical disparities in myelodysplastic syndrome mortality trends in Spain (1999–2022)
|
Martín-Rojas, Reyes María
|
|
|
26 |
10 |
p. 2693-2700
|
artikel
|
| 31 |
Upregulation of NPC1 and its association with poor prognosis in gastric cancer
|
Tang, Wei
|
|
|
26 |
10 |
p. 2665-2673
|
artikel
|
| 32 |
Vaginal micro-environment disorder promotes malignant prognosis of low-grade cervical intraepithelial neoplasia: a prospective community cohort study in Shanxi Province, China
|
Liu, Jiamin
|
|
|
26 |
10 |
p. 2738-2748
|
artikel
|
Tijdschrift beschrijving